Contract Manufacturing Industry News
-
Stevanato Group Appoints Riccardo Butta As President, Americas
2/2/2022
The appointment of a dedicated executive to lead the Company’s long-term strategy in the Americas is indicative of the growing regional demand trends and the Company’s commitment to broaden its footprint, accelerate its market penetration and improve proximity to its customers in this important region.
-
PCI Invests In Second Commercial Scale Contained Manufacturing Facility
1/19/2022
PCI Tredegar is excited to announce significant investment in additional capacity and capabilities, adding to the already world-recognized Center of Excellence for the manufacturing of highly potent products.
-
Adare Pharma Solutions Announces Appointment Of Tom Sellig As Chief Executive Officer
1/6/2022
Sellig, a 30-year veteran of the pharmaceutical and life sciences industries, will lead the organization in supporting pharmaceutical companies in the development and manufacturing of transformative medicines that improve patient health and outcomes.
-
Fareva And ApiJect Sign A Licensing Agreement To Create A France-Based 500M Unit Annual Capacity For Single-Dose Prefilled Vaccine Injections
12/9/2021
Fareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect’s innovative prefilled injector technology.
-
Pharmaceutics International, Inc. (Pii) To Platform West Pharmaceutical Services, Inc.’s Daikyo Crystal Zenith® Container-Closure Components For Aseptic Fill-Finish
8/4/2021
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), will include Daikyo Crystal Zenith® (CZ) container-closure components, offered by West Pharmaceutical Services, Inc. (West), as part of its aseptic fill-finish capabilities across vials, syringes and cartridges.
-
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN®
6/16/2021
Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, announced that it has entered into an agreement with Jubilant HollisterStier for manufacturing of vaccine candidate COVAXIN® for the US and Canadian markets.
-
Jubilant HollisterStier Announces $92M Expansion For Sterile Injectable Manufacturing Capacity
6/3/2021
This investment is being made to set up a high-speed 400 vials a minute injectable fill line with isolator technology, which will enhance the Spokane facility’s capacity by 50%.
-
Samsung Biologics And KAHR Medical Announce Development And Manufacturing Agreement For Cancer Immunotherapy Drug Candidate
6/2/2021
Samsung Biologics has announced a manufacturing agreement with KAHR Medical for cancer immunotherapy drug candidate DSP502, a TIGITxPD1 fusion protein. The agreement will streamline cell line development to IND filing process to enable seamless manufacturing of DSP502.
-
Supporting Biotech Jobs In Middle Tennessee Through Student Outreach
4/23/2021
Cooperative efforts between a high-tech CRO/CDMO, a nonprofit coalition, and local schools are empowering the next generation of Tennessee health science innovators.
-
Nanoform And Aprecia Collaborate To Advance 3D Printed Nanomedicines
4/21/2021
By exploring the synergies between Nanoform and Aprecia’s respective technologies in the field of nanoparticle-enabled 3DP dosage forms, the partnership seeks to provide new possibilities for patient-centric therapies.